• Amikacin Sulfate: Intracellular Research Workflows

  2026-09-28

  Build reproducible Amikacin Sulfate assays that connect extracellular MIC testing with intracellular CFU reduction and granuloma-oriented in vivo studies. The workflow emphasizes concentration-response design, cell-associated bacterial recovery, storage discipline, and careful separation of direct evidence from translational hypotheses.

• Tomivosertib: Reading Translation Beyond p-eIF4E

  2026-09-28

  Tomivosertib is a potent MNK1 inhibitor for testing how kinase signaling shapes selective mRNA translation. This article connects target engagement to phenotype, helping researchers interpret results across cancer, neuronal, and metabolic models without treating a single phospho-readout as proof of biological effect.

• Carbapenemase Transfer in Guangdong CREC

  2026-09-27

  A multicentre study of 54 carbapenem-resistant Enterobacter cloacae isolates found that carbapenemase-encoding genes were common, frequently associated with plasmids, and often transferable in laboratory conjugation assays. By combining gene localization, susceptibility testing, mobile-element profiling, and strain typing, the study distinguishes gene spread from clonal spread and offers practical evidence for hospital surveillance.

• H₂S Deficiency and ER Stress in Diabetic Cardiomyopathy

  2026-09-26

  This study links reduced endogenous hydrogen sulfide (H₂S) with cardiac lipotoxicity and endoplasmic reticulum (ER) stress across patient samples, diabetic rats, and palmitate-treated cardiomyocytes. Its intervention results suggest that H₂S supplementation may lessen myocardial injury, while also identifying ER stress as a possible therapeutic and experimental focus.

• Early Pheromone Exposure and Adult Neurodegeneration

  2026-09-25

  Peng et al. show that pheromones sensed during the L1 stage of C. elegans development can reshape neural signaling and increase neurodegeneration in adulthood. Their findings connect two sensory-neuron pathways through AIA interneurons to insulin-like signaling and reduced neuronal autophagy, offering a mechanistic example of how early environmental cues can influence later proteostasis.

• Seeing Radiosensitization: BLI for Translational Oncology

  2026-09-25

  Bioluminescence imaging can help translational teams follow tumor response over time, but its value depends on understanding what the signal measures. Using a 2025 lung cancer brain-metastasis study as a case study, this article connects experimental design to D-Luciferin substrate selection and outlines practical limits for interpreting in vivo imaging.

• ALC-0315 for LNP Formulation and QC

  2026-09-24

  ALC-0315 is an ionizable amino lipid for researchers formulating lipid nanoparticles for mRNA and other nucleic acid drug delivery workflows. It is intended for controlled organic-solvent formulation—not as a water-soluble reagent or a stand-alone delivery system—and its performance must be assessed in the complete LNP formulation.

• Lipo3K Transfection Reagent for ASO Assays

  2026-09-24

  Pair a low-toxicity lipid delivery workflow with careful testing of nucleic-acid designs, from plasmid reporters to siRNA controls. The article’s pH-responsive ASO findings suggest practical assay questions—but do not establish Lipo3K as a validated delivery method for those ASOs.

• Nonivamide: TRPV1 Workflows for Cancer Research

  2026-09-23

  Use Nonivamide as a TRPV1 probe for acute calcium signaling and as a candidate for dose- and time-resolved cancer cell assays. A dermatitis study offers a useful sensory-neuron assay framework, but its capsaicin findings should not be mistaken for direct testing of Nonivamide.

• From mRNA Capping to Bladder Cancer Translation

  2026-09-23

  A translational analysis of p21 mRNA–loaded lipid nanoparticles for bladder cancer, showing how localized delivery, tumor suppressor biology, and disciplined mRNA manufacturing can converge. The article also positions EZ Cap™ Reagent GG as an upstream reagent to evaluate within a controlled IVT and LNP development workflow.

• Palonosetron for CINV and RINV: 2013 Review

  2026-09-22

  This review synthesized pharmacology, clinical trials, guideline positioning, and emerging combination strategies for palonosetron hydrochloride in radio- and chemotherapy-induced nausea and vomiting. Its main contribution was to connect high-affinity, long-lasting 5-HT3 receptor antagonism with improved control of delayed symptoms after moderately emetogenic chemotherapy, while identifying evidence gaps in multiple-day treatment and broader combination regimens.

• seRNA-NPCm Drives Nasopharyngeal Carcinoma Metastasis

  2026-09-22

  The 2023 study identifies a carcinogen-responsive super-enhancer RNA, seRNA-NPCm, as a regulator of nasopharyngeal carcinoma metastasis. Integrated transcriptomic, nascent-transcription, chromatin, functional, and patient-tissue analyses connect seRNA-NPCm with an NPM1/c-Myc/NDRG1 regulatory axis and provide a mechanistic framework for studying carcinogen-associated enhancer dysregulation.

• Zebrafish CCK-8 and Anxiety-Like Behavior

  2026-09-21

  The reference study mapped CCK-like immunoreactivity in the zebrafish brain and tested two sulfated CCK octapeptide forms using intracerebroventricular administration. Both peptides produced dose-dependent anxiety-like behavior at the highest tested dose, while proglumide attenuated the response, supporting CCK receptor signaling as a conserved neurobehavioral pathway.

• Digoxin Workflows for Ion-Pump and CHIKV Research

  2026-09-21

  Digoxin provides a mechanistically defined way to study Na+/K+ ATPase signaling, cardiac contractility modulation, and cell-context-dependent inhibition of chikungunya virus infection. This workflow-focused guide covers dose design, solvent control, translational model selection, and troubleshooting for cardiovascular and antiviral experiments.

• ALC-0315: Practical LNP Formulation Guide

  2026-09-20

  ALC-0315 is an ionizable amino lipid for developing lipid nanoparticles used in nucleic acid drug delivery, including mRNA vaccine research. It is intended for controlled organic-solvent formulation workflows, not as a water-soluble standalone reagent or evidence of a validated clinical formulation.

8346 records 1/557 page Next 12345 下5页 Last page